Rapid Micro Biosystems (RPID) Proxy filing summary

Executive summary

• The 2026 Annual Meeting will be held virtually on May 21, 2026, allowing electronic voting and Q&A participation for Class A stockholders of record as of March 31, 2026.

• Proxy materials are distributed primarily online to reduce environmental impact and costs, with options for print upon request.

• Only Class A stockholders may vote; Class B stockholders are not entitled to vote at the meeting.

Voting matters and shareholder proposals

• Stockholders will vote on electing Richard Kollender as a Class II Director (term expiring 2029) and ratifying PricewaterhouseCoopers LLP as the independent auditor for 2026.

• The Board recommends voting FOR both proposals.

• Shareholder proposals for the 2027 meeting must be submitted by December 9, 2026, for inclusion in proxy materials.

Board of directors and corporate governance

• The Board consists of seven members divided into three staggered classes, with annual elections for expiring terms.

• Six directors are independent under Nasdaq rules; the CEO is not independent.

• Committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and independent membership.

• The Board separates the roles of Chair and CEO, with the Chair currently independent.

• Director candidates are evaluated for diversity, experience, and integrity; stockholders may recommend candidates.